Craft

Alzheon

Total Funding

$37.1 M

Alzheon Summary

Company Summary

Overview
Alzheon is a biotechnology company focused on womanchild brain health, memory and aging, developing transformative treatments for Alzheimer’s disease and other neurodegenerative disorders. The company is building a pipeline of innovative drugs to improve the lives of patients by preventing the cognitive and functional decline associated with neurodegeneration.
Type
Private
Status
Active
Founded
2013
HQ
Framingham, MA, US | view all locations
Website
http://alzheon.com/
Cybersecurity rating
Sectors

Key People

  • Martin Tolar

    Martin Tolar, Founder, President, CEO and Director

  • Neil Flanzraich

    Neil Flanzraich, Executive Chairman of the Board of Directors

    • Susan Abushakra

      Susan Abushakra, Chief Medical Officer

    • John Hey

      John Hey, Chief Scientific Officer

    Operating MetricsView all

    Patents (US)

    2

    Mar, 2018

    Patents Pending (US)

    4

    Mar, 2018

    Patents (Foreign)

    22

    Mar, 2018

    LocationsView all

    1 location detected

    • Framingham, MA HQ

      United States

      111 Speen St #306

    Alzheon Financials

    Summary Financials

    Net income (FY, 2017)
    ($5.5M)
    Cash (FY, 2017)
    $6.4M
    EBIT (FY, 2017)
    ($4.1M)

    Footer menu